These Clinical Trials Could be Game Changers in the Latter Half of 2023
source: shutterstock.com

These Clinical Trials Could be Game Changers in the Latter Half of 2023

In a story from BioPharma Dive, a number of high-profile clinical trials are under way that could see conclusive results by the end of 2023. While some of these are…

Continue Reading These Clinical Trials Could be Game Changers in the Latter Half of 2023
Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial
source: unsplash.com

Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial

According to a story from PR Newswire, the pharmaceutical company Saol Therapeutics has recently announced that it has completed its enrollment goals for its phase 3 clinical trial. This trial…

Continue Reading Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial
Combination Therapy for Hepatocellular Carcinoma Fails to Achieve Trial Endpoints
source: pixabay.com

Combination Therapy for Hepatocellular Carcinoma Fails to Achieve Trial Endpoints

According to a story from Market Watch, the drug companies Merch and Eisai recently announced an update on their phase 3 clinical trial. This clinical trial was evaluating a combination…

Continue Reading Combination Therapy for Hepatocellular Carcinoma Fails to Achieve Trial Endpoints

Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study

[Cancer Management and Research](cancer-management-and-research-journal) » [Volume 14](cancer-management-and-research-archive55-v1655) Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study Authors [Zhang S](author_profile.php?id=1654738)…

Continue Reading Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study
A New Collaboration will Support the Distribution of a Novel Therapy for Arginase 1 Deficiency in the Middle East and Europe
source: pixabay.com

A New Collaboration will Support the Distribution of a Novel Therapy for Arginase 1 Deficiency in the Middle East and Europe

Aeglea Biotherapeutics has just announced a new collaboration with Immedica to bring pegzilarginase to other countries outside of the United States. They have created a license and supply agreement to…

Continue Reading A New Collaboration will Support the Distribution of a Novel Therapy for Arginase 1 Deficiency in the Middle East and Europe